• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血红蛋白 C 性状伴发双侧中央视网膜静脉阻塞。

HEMOGLOBIN C TRAIT PRESENTING WITH BILATERAL CENTRAL RETINAL VEIN OCCLUSION.

机构信息

Department of Ophthalmology, Jones Eye Institute, Little Rock, Arkansas.

出版信息

Retin Cases Brief Rep. 2023 Jan 1;17(1):44-46. doi: 10.1097/ICB.0000000000001097.

DOI:10.1097/ICB.0000000000001097
PMID:33229918
Abstract

PURPOSE

To report a case of bilateral sequential, central retinal vein occlusion (CRVO) in a man with newly diagnosed hemoglobin C trait.

METHODS

A 67-year-old man presented with a one-month history of declining visual acuity. He was diagnosed with left CRVO. Bilateral temporal retinal ischemia and arteriovenous anastomoses on fluorescein angiography suggestive of sickle cell retinopathy prompted a systemic work-up. Hemoglobin electrophoresis revealed an underlying hemoglobin C trait. Six-months after his initial presentation, the patient developed symptomatic right CRVO.

RESULTS

The initial left CRVO was complicated by optic disc swelling and macular edema. Intravitreal antiangiogenic therapy was initiated and the macular edema resolved. The left eye subsequently developed an epiretinal membrane which was surgically removed. Macular edema in the right eye also resolved after intravitreal antiangiogenic therapy.

CONCLUSION

This is the first reported case of bilateral CRVO in a case of hemoglobin C trait. It is possible that erythrocyte inflexibility, caused by hemoglobin C-induced dehydration and crystallization, acted concomitantly with hypertension to produce occlusive microangiopathy. This case highlights the need for further investigation in patients presenting with central retinal vein occlusion, especially when bilateral, or when retinal angiography reveals bilateral pathology.

摘要

目的

报告 1 例新诊断为血红蛋白 C 特征的男性双侧先后发生的中央视网膜静脉阻塞(CRVO)病例。

方法

1 名 67 岁男性因视力下降 1 个月就诊。诊断为左侧 CRVO。荧光素血管造影显示双侧颞侧视网膜缺血和动静脉吻合,提示镰状细胞视网膜病变,因此进行了系统检查。血红蛋白电泳显示存在潜在的血红蛋白 C 特征。初次就诊后 6 个月,患者出现右侧 CRVO 症状。

结果

最初的左侧 CRVO 并发视盘肿胀和黄斑水肿。给予眼内抗血管生成治疗后黄斑水肿消退。左眼随后出现视网膜内膜,通过手术切除。右眼的黄斑水肿也在眼内抗血管生成治疗后消退。

结论

这是首例报告的血红蛋白 C 特征双侧 CRVO 病例。可能是由于血红蛋白 C 引起的脱水和结晶导致的红细胞僵硬,与高血压同时作用,导致闭塞性微血管病。该病例强调了在出现中央视网膜静脉阻塞的患者中,特别是当双侧出现或视网膜血管造影显示双侧病变时,需要进一步调查。

相似文献

1
HEMOGLOBIN C TRAIT PRESENTING WITH BILATERAL CENTRAL RETINAL VEIN OCCLUSION.血红蛋白 C 性状伴发双侧中央视网膜静脉阻塞。
Retin Cases Brief Rep. 2023 Jan 1;17(1):44-46. doi: 10.1097/ICB.0000000000001097.
2
Clinical, anatomical, and electrophysiological assessments of the central retina following intravitreal bevacizumab for macular edema secondary to retinal vein occlusion.玻璃体内注射贝伐单抗治疗视网膜静脉阻塞继发黄斑水肿后对视网膜中央的临床、解剖学及电生理评估
Int Ophthalmol. 2016 Feb;36(1):21-36. doi: 10.1007/s10792-015-0066-6. Epub 2015 Mar 29.
3
Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.玻璃体内注射曲安奈德治疗视网膜中央静脉阻塞相关的黄斑水肿。
Arch Ophthalmol. 2004 Aug;122(8):1131-6. doi: 10.1001/archopht.122.8.1131.
4
Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.玻璃体内注射曲安奈德治疗与视网膜中央静脉阻塞和半侧视网膜静脉阻塞相关的黄斑水肿。
Retina. 2005 Oct-Nov;25(7):846-50. doi: 10.1097/00006982-200510000-00005.
5
OUTER RETINAL LAYER CHANGES AFTER DEXAMETHASONE IMPLANT FOR CENTRAL RETINAL VEIN OCCLUSION.地塞米松植入治疗视网膜中央静脉阻塞后视网膜外层的变化
Retina. 2017 Oct;37(10):1888-1895. doi: 10.1097/IAE.0000000000001429.
6
SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.玻璃体内注射Ozurdex®治疗视网膜静脉阻塞合并黄斑囊样水肿的频域光学相干断层扫描图像特征
Eur J Ophthalmol. 2011 Sep-Oct;21(5):631-6. doi: 10.5301/EJO.2011.7428.
7
Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10.视网膜静脉阻塞患者视力和视网膜厚度结果的基线预测因素:视网膜静脉阻塞标准护理与皮质类固醇治疗研究报告10
Ophthalmology. 2011 Feb;118(2):345-52. doi: 10.1016/j.ophtha.2010.06.034.
8
Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.玻璃体内注射贝伐单抗(阿瓦斯汀)治疗视网膜中央静脉阻塞所致黄斑水肿的短期研究。
Retina. 2006 Mar;26(3):279-84. doi: 10.1097/00006982-200603000-00005.
9
Ranibizumab for the treatment of macular edema associated with perfused central retinal vein occlusions.雷珠单抗治疗与灌注型视网膜中央静脉阻塞相关的黄斑水肿。
Ophthalmology. 2008 Oct;115(10):e47-54. doi: 10.1016/j.ophtha.2008.06.021. Epub 2008 Aug 16.
10
Sustained Benefits from Ranibizumab for Central Retinal Vein Occlusion with Macular Edema: 24-Month Results of the CRYSTAL Study.雷珠单抗治疗黄斑水肿型视网膜中央静脉阻塞的持续获益:CRYSTAL研究24个月结果
Ophthalmol Retina. 2018 Feb;2(2):134-142. doi: 10.1016/j.oret.2017.05.016. Epub 2017 Sep 9.